drugset / Trial / NCT00685347
Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate, using an exercise challenge approach, the dose response of levalbuterol HFA MDI in pediatric subjects with asthma
Timeline
- Start
- 2003-01
- Primary completion
- 2003-06
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levalbuterol | Other / unclassified | 45 ug | — |
| Subject | Levalbuterol | Other / unclassified | 90 ug | — |
| Subject | Levalbuterol | Other / unclassified | 180 ug | — |
| Comparator | racemic albuterol | Unknown | 90 ug | — |
| Comparator | racemic albuterol | Unknown | 180 ug | — |
| Comparator | racemic albuterol | Unknown | 360 ug | — |